linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board of Directors  
Bafna Pharmaceuticals Ltd.
 
BSE Code 532989
ISIN Demat INE878I01022
Book Value 40.64
NSE Code BAFNAPH
Dividend Yield % 0.00
Market Cap 4185.99
P/E 37.71
EPS 4.69
Face Value 10  
Company SecretaryA Mohanachandran
Non Executive Independent DirectorR Chitra
Navin Kumar
Palamadai Krishnan Sundaresan
Whole Time DirectorShanmugam Hemalatha
Vinayak Dinesh Dendukuri
Non Independent & Non Executive DirectorAkila Chintalapati Raju
Upendar Mekala Reddy
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.